Melanoma Institute Australia
In research, Melanoma Institute Australia stands highest in Medicine (#4,874 of 10,443 worldwide) and Health Sciences (#6,472 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 33.5× its share of world research.
- World rank, 2022–2025
- #8,450 of 28,054 · #5,989 all time
- Rank in Australia
- #138 of 391
- Research works
- 701 ▲ 27% vs 2013–17
- Citations
- 34k 48.2 per fractional work
- Top-10% rate
- 20.6% record average 16.5%
- Open access
- 40% world 28%
What is Melanoma Institute Australia known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #4,874 of 10,443 | 20.8% | 90 | #4730 | |
| Health SciencesDomain | #6,472 of 11,982 | 20.5% | 92 | #6361 |
Each strip is that field’s whole ranked pool, with the notch where Melanoma Institute Australia sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Melanoma Institute Australia specialise in?
Where its research is concentrated relative to its size: Oncology takes 33.5× the share of its output that it takes of world research.
- OncologySubfield · 54.4 works34×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.2×. Every wedge is a field page.
- Immunology and Microbiology 6.2×
- Biochemistry, Genetics and Molecular Biology 3.3×
- Medicine 3.2×
- Veterinary 1.2×
- Nursing 0.6×
- Dentistry 0.5×
- Economics, Econometrics and Finance 0.5×
- Neuroscience 0.4×
- Agricultural and Biological Sciences 0.4×
- Chemistry 0.4×
- Mathematics 0.3×
- Health Professions 0.3×
- Computer Science 0.3×
- Environmental Science 0.2×
- Chemical Engineering 0.2×
- Psychology 0.2×
- Engineering 0.2×
- Earth and Planetary Sciences 0.1×
- Decision Sciences 0.1×
- Materials Science 0.1×
- Arts and Humanities 0.1×
- Business, Management and Accounting 0.0×
- Social Sciences 0.0×
Who are the top researchers at Melanoma Institute Australia?
Ranked on the composite score, Georgina V. Long, Kerwin F. Shannon and Matteo S. Carlino lead among researchers whose main affiliation is Melanoma Institute Australia.
- 1 Georgina V. Long Australia · #3,500 worldwide 2.8k citations · 211 works
- 2 Kerwin F. Shannon Australia · #24,899 worldwide 1.4k citations · 36 works
- 3 Matteo S. Carlino Australia · #137,368 worldwide 412 citations · 85 works
- 4 Inês Pires da Silva Australia · #256,795 worldwide 83 citations · 34 works
- 5 Alexander M. Menzies Australia · #287,707 worldwide 295 citations · 81 works
- 6 Omgo E. Nieweg Australia · #761,140 worldwide 29 citations · 22 works
- 7 Victoria Atkinson Australia · #869,162 worldwide 52 citations · 17 works
Which keywords describe research at Melanoma Institute Australia?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Melanoma, Skin Cancer, Survival Analysis, Deep Learning, Tumor Staging, Sentinel Lymph Node Biopsy and Dermoscopy.
- Genomic Instability
- Targeted Therapy
- Vaccine Adjuvants
- Innate Immunity
- Nonmelanoma Skin Cancer
- Dendritic Cells
- Immunity
- Squamous Cell Carcinoma
- CAR T Cells
- Metastasis
- Tumor Regression
- Cell Proliferation
- Cancer Therapy
- Cancer Immunotherapy
- Immune Checkpoint Blockade
- Genetic Alterations
- Sentinel Lymph Node Biopsy
- Survival Analysis
- Epidemiology
- Melanoma
- Immunotherapy
- Deep Learning
- Skin Cancer
- Tumor Staging
- Dermoscopy
- Tumor Microenvironment
- PD-1 and PD-L1
- Immune Response
- BRAF gene
- MAP Kinase
- Photodynamic Therapy
- Lymphoma
- Chimeric Antigen Receptor
- Basal Cell Carcinoma
- Antigen Presentation
- Organ Transplant Recipients
- Skin Cancers
- Tumor Antigen
- Chemotherapy
- Prognostic Factors
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy38▲ 37×18 topics
- Melanoma37▲ 430×2 topics
- Deep Learning29▲ 6.0×9 topics
- Epidemiology29▲ 5.2×40 topics
- Skin Cancer27▲ 251×2 topics
- Survival Analysis26▲ 67×6 topics
- Tumor Staging26▲ 160×2 topics
- Sentinel Lymph Node Biopsy25▲ 211×2 topics
- Dermoscopy25▲ 407×1 topic
- Genetic Alterations25▲ 230×1 topic
- Tumor Microenvironment15▲ 23×6 topics
- Immune Checkpoint Blockade14▲ 89×1 topic
- PD-1 and PD-L114▲ 89×1 topic
- Cancer Immunotherapy14▲ 62×3 topics
- Immune Response13▲ 16×10 topics
- Cancer Therapy12▲ 15×8 topics
- BRAF gene12▲ 490×1 topic
- Cell Proliferation12▲ 94×3 topics
- MAP Kinase12▲ 490×1 topic
- Tumor Regression8▲ 50×2 topics
- Photodynamic Therapy8▲ 25×5 topics
- Metastasis8▲ 16×8 topics
- Lymphoma8▲ 33×3 topics
- CAR T Cells7▲ 69×1 topic
- Chimeric Antigen Receptor7▲ 69×1 topic
- Squamous Cell Carcinoma7▲ 57×3 topics
- Basal Cell Carcinoma7▲ 124×2 topics
- Immunity7▲ 12×3 topics
- Antigen Presentation7▲ 52×2 topics
- Dendritic Cells7▲ 52×2 topics
- Organ Transplant Recipients7▲ 120×2 topics
- Nonmelanoma Skin Cancer6▲ 179×1 topic
- Skin Cancers6▲ 179×1 topic
- Innate Immunity6▲ 14×3 topics
- Tumor Antigen6▲ 70×1 topic
- Vaccine Adjuvants6▲ 70×1 topic
- Chemotherapy4▲ 3.5×16 topics
- Targeted Therapy3▲ 11×5 topics
- Prognostic Factors3▲ 4.8×12 topics
- Genomic Instability2▲ 15×2 topics
Which research topics does Melanoma Institute Australia publish most on?
By volume in 2022–2025: Cutaneous Melanoma Detection and Management, Cancer Immunotherapy and Biomarkers, Melanoma and MAPK Pathways and CAR-T cell therapy research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cutaneous Melanoma Detection and Management Oncology 25 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 14 works
- 3 Melanoma and MAPK Pathways Molecular Biology 12 works
- 4 CAR-T cell therapy research Oncology 7 works
- 5 Nonmelanoma Skin Cancer Studies Epidemiology 6 works
- 6 Immunotherapy and Immune Responses Immunology 6 works
- 7 Cancer Genomics and Diagnostics Cancer Research 2 works
- 8 Cell Image Analysis Techniques Biophysics 2 works
- 9 Brain Metastases and Treatment Pulmonary and Respiratory Medicine 2 works
- 10 Skin Protection and Aging Dermatology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Melanoma Institute Australia's research output changed?
Output in 2018–2022 was 27% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Sydney
- The University of Sydney
- UNSW Sydney
- Macquarie University
- University of Technology Sydney
- Royal Prince Alfred Hospital
- Westmead Hospital
- Prince of Wales Hospital
- Children's Hospital at Westmead
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.